| 中文名称 | 千金藤素 |
|---|---|
| 中文别名 | 千金藤素;千金藤碱;头花千金藤碱;千金藤啶碱;千金藤素对照品;西法安生(R);金藤素;六羰基铬;头花千金藤碱对照品;盐酸氯吉兰;千金藤素 植物提取物,标准品,对照品;千金藤素(分析标准品);千金藤素(对照品) |
| 英文名称 | Cepharanthine |
| 英文别名 | Cepharanthine;6',12'-DIMETHOXY-2,2'-DIMETHYL-6,7-(METHYLENEBIS(OXY)OXYACANTHAN);CEPHARANTHIN;OXYACANTHAN,6',12'-DIMETHOXY-2,2'-DIMETHYL-6,7-(METHYLLENEBIS (OXY))-;cepharantin;o-methylcepharanoline;Stephanotis;CEPHARANTHINE(RG);[methylenebis(oxy)];6',12'-dimethoxy-2,2'-dimethyl-6,7-[methylenebis-(oxy)]oxyacanthan;6,7-methanediyldioxy-6',12'-dimethoxy-2,2'-dimethyl-oxyacanthane;CEPHARANTHINUM;ChroMiuM(0) hexacarbonyl;sepharanthine;(+)-Cepharanthine;6′,12′-Dimethoxy-2,2′-dimethyl-6,7-(methylenebis(oxy))oxyacanthan;CEP;NSC 623442;[14aS-(14aR*,26aS*)]-2,3,13,14,14a,15,26,26a-octahydro-22,30-dimethoxy-1,14-dimethyl- H-4,6:16,19-Dietheno-21,25-metheno-12H-[1,3]dioxolo[4,5-g]pyrido[2′,3′:17,18][1,10]dioxacycloeicosino[2,3,4-ij]isoquinoline;6',12'-Dimethoxy-2,2'-dimethyl-6,7-(methylenebis(oxy))-oxyacanthan;[ "" ];Cepharanthine [JAN];C37H38N2O6;6',12'-Dimethoxy-2,2'-dimethyl-6,7-(methylenebis(oxy))oxyacanthan;7592YJ0J6T;NSC623442;Cepharanthine (JAN);ecaene (non-preferred name);DSSTox_RID_81253;DSSTox_CID_25957;DSSTox_GSID_45957;Oxyacanthan, 6',12'-dimethoxy-2,2'-dimethyl-6,7-(methylenebis(oxy))-;Cepharanthin,(S);NCGC0009;Oxyacanthan,12'-dimethoxy-2,2'-dimethyl-6,7- [methylenebis(oxy)]-;Cepharanthin; (+)-Cepharanthine; O-Methylcepharanoline;BCP08971;CHEMBL1473842;NCGC00095194-02;(14S,27R)-22,33-dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.2^{16,19.1^{3,10.1^{21,25.0^{4,8.0^{31,35.0^{14,39]nonatriaconta-1(33),3(39),4(8),9,16(38),17,19(37),21,23,25(36),31,34-dodecaene;NCGC00095194-03;NCGC00095194-01;DTXSID00859398;22,33-Dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.2~16,19~.1~3,10~.1~21,25~.0~4,8~.0~14,39~.0~31,35~]nonatriaconta-1(33),3,8,10(39),16,18,21(36),22,24,31,34,37-dodecaene (non-preferred name);HMS3370G06;1H-4,6:16,19-Dietheno-21,25-metheno-12H-[1,3]dioxolo[4,5-g]pyrido[2',3':17,18][1,10]dioxacycloeicosino[2,3,4-ij]isoquinoline,2,3,13,14,14a,15,26,26a-octahydro-22,30-dimethoxy-1,14-dimethyl-,(14aS,26aR)-;NCGC00095194-04;HY-N6972;AB00643356_08;Pharmakon1600-01505322;481-49-2;NSC-758965;A871948;Cepharanthine, >=95% (HPLC);SR-01000779734;D01035;MLS000728518;CHEBI:3546;SMR000445632;(14S,27R)-22,33-dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.2??,??.1?,??.1??,??.0?,?.0??,??.0??,??]nonatriaconta-1(33),3,8,10(39),16,18,21(36),22,24,31,34,37-dodecaene;4-27-00-09061 (Beilstein Handbook Reference);UPCMLD-DP054;AC-15206;Q15410888;C09391;SBI-0207049.P001;Cepharanthine, >=98% (HPLC);SPBio_000783;s4238;CHEMBL449782;12-O-Methylcepharanoline;NSC758965;Cepharanthine (TN);DTXCID4025957;HMS1922J12;HMS2232F21;NCGC00161621-05;SDCCGMLS-0066893.P001;NSC-623442;Tox21_111483;BRD-K96194081-001-06-0;SR-01000779734-4;CCG-40294;SR-01000779734-3;M2968;NCGC00161621-01;CS-0007138;BSPBio_003563;CEPHARANTHINE [MI];22,33-Dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.... |
| CAS No. | 481-49-2 |
| 分子式 | C37H38N2O6 |
| 分子量 | 606.71 |
4-(2-((2R,3R)-3-(2,5-二氟苯基)-3-羟基-4-(1H-1,2,4-三唑-1-基)丁-2-基)噻唑-4-基)苯甲腈
N-(丁基磺酰基)-O-[4-(4-哌啶基)丁基]-L-酪氨酸盐酸盐一水合物
2-(4-(1-羟基-4-(4-(羟基二苯基甲基)哌啶-1-基)丁基)苯基)-2-甲基丙酸
7-环戊基-N,N-二甲基-2-((5-(哌嗪-1-基)吡啶-2-基)氨基)-7H-吡咯并[2,3-d]嘧啶-6-甲酰胺
(1-((2R,3R,4S,5R)-3,4-二羟基-5-甲基四氢呋喃-2-基)-5-氟-2-氧代-1,2-二氢嘧啶-4-基)氨基甲酸戊酯
((3S,5R)-5-((1H-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氢呋喃-3-基)甲基 4-甲基苯磺酸酯
N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-4-胺
(6R,7R)-3-甲基-7-[(R)-2-氨基-2-苯乙酰氨基]-8-氧-5-硫杂-1-双环[4.2.0]辛-2-烯-2-甲酸
(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇
(2R,3R,4S,5R)-2-(4-氨基吡咯并[2,1-F][1,2,4]三嗪-7-基)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-甲腈
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。
CopyRight @2025 广东元丰化学试剂有限公司 版权所有 | 隐私政策 条款及条件 | 粤ICP备2025403430号-1
技术支持:库价化学